To review initial clinical presentation, treatment course, and results of ethanol embolotherapy for foot arteriovenous malformations (AVMs) and to analyze prognostic factors for treatment results.Twenty-nine patients (mean age, 31.3 years; range, 9-59) who underwent ethanol embolotherapy between 1999 and 2012 were retrospectively reviewed. Initial clinical manifestation, medical history, treatment results of ethanol embolotherapy, and major and minor complications were reviewed in detail. Two radiologists analyzed the extent of AVM involvement, modified angiographic classification by Cho et al, presence of feeding artery aneurysm, degree of devascularization after embolotherapy, and treatment results. From the analysis, prognostic factors for final outcome were assessed.The most common symptom was pain (83%; 24/29), followed by ulcer (52%; 15/29), mass (48%; 14/29), varicosity (38%; 11/29), and swelling (31%; 9/29). On baseline angiogram, lesion extent 25% having 55%. There was no correlation between angiographic type and outcome (P > .05; ρ = 0.143).Ethanol embolotherapy for foot AVMs can be as effective and safe as for other body parts. From the analysis of angiographic findings, foot AVMs that involve <25% of the area of the foot are prone to show better treatment outcomes from ethanol embolotherapy.